You may submit your abstract until February 3, 2015 at 11:59 PM EST. Please bear in mind that all submissions will be considered for poster presentations only. To submit your abstract, CLICK HERE.
To download an abstract template with content guidelines: CLICK HERE
All authors must submit their abstract electronically. This is the ONLY option for abstract submission.
Late Breaking abstracts are being solicited for poster presentation only.
The categories for poster abstract submission, and the scope of each proposed general session and symposium are available on the Program tab of this website.
This year, the meeting will be organized into five thematic areas:
1. Translation: Focused on translating research from the lab to the clinic, advancing biomaterials in their product development life cycle
2. Biofabrication/Biomanufacturing: Manufacturing techniques e.g. nanoprinting, rapid prototyping, microfluidic based printing, etc.
3. Multi-Functional Biomaterial Design: Drug/gene delivery, biosensing, and complex tissue regeneration, etc.
4. Biocompatibility and Immune Engineering: How to harness/modulate the immune response (innate and adaptive) for biomaterial design or technology translation
5. Other topics of interest to the biomaterials community
The title should be brief, clearly indicating the nature of the presentation. When entering your title online, use mixed case (do not use all caps) and do not put a period at the end of the title.
Example: This is a Properly Formatted Abstract Title
List the authors according to the instructions given online. Author information should also be included in the abstract as formatted in the template. If authors’ names appear on more than one abstract, the names must be entered identically on each abstract to ensure proper, non-repetitive indexing in publication. Otherwise, the author’s name will appear multiple times as SFB cannot assume that the multiple listings refer to the same author. Please consult with your co-authors on how they would like their names to appear prior to the submission of the abstract.
In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, SFB requires all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author’s view on the subject. Examples include but are not limited to:
Disclosure information is collected on the online abstract form. Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the conflict of interest/disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.
Keywords will be used for indexing purposes. Choose up to four keywords from the list on the online abstract submission site. At least one keyword must be selected.
Content should be organized as follows:
NOTE: Common reasons for abstract rejection are:
Tables and graphs should be embedded in the submitted Microsoft Word or Adobe Acrobat document and must be of sufficient resolution to be reproduced clearly, typically at 300 dpi.
Once your abstract has been completed, you will receive an e-mail acknowledgment to yourself and/or your co-authors from the online submission system.
You may revise your abstract until 11:59 p.m. Eastern Standard Time on February 3, 2015 at 11:59 p.m. EST, by returning to the site and logging in again.
If the abstract must be withdrawn, the SFB office must be notified in writing via fax at (856) 439-0525 or via e-mail at email@example.com.
Accepted abstracts will be published in the Transactions of the Society For Biomaterials, a referenced, copyrighted publication of the Society For Biomaterials.Under SFB copyright, authors are granted free use of SFB abstract content in other publications and abstract submissions, provided that such content is not substantially equivalent. Previously published materials may only be submitted with permission of the copyright holder, and must be properly referenced. The submitting author is responsible for securing any required copyright permissions.
Submit only ONE abstract for each presentation; DO NOT submit multiple copies of the same abstract and DO NOT submit in masked format.
Accepted authors are expected to pay their own travel expenses and conference registration fee(s).
Submitted abstracts that provide a substantial contribution to the field of biomaterials and follow the published abstract submission instructions will be accepted for peer review. Reviewers will be selected by the Program Committee. Abstracts that do not meet the focus of the symposium or general session category as requested by the authors may be reassigned to another symposium or general session.
The person submitting the abstract identifies the author who will be designated as the presenting author. The presenting author will serve as the primary contact on the abstract. The presenter must be one of the co-authors listed on the submitted abstract. The presenting author will be the main point of contact for information regarding the submission and is responsible for the following:
The presenting author is expected to present the paper. If emergencies at the time of the meeting prohibit the participation of the designated author, the chair(s) of the session and the Program Committee chair must be notified of the name of the replacement speaker prior to the meeting. It is the presenting author’s obligation to ensure that the abstract is presented. Failure to present an oral or poster presentation at the scheduled times may result in the presenting author being barred from making presentations at future SFB meetings and will result in a $50 publishing fee to the corresponding author.
Notification of acceptance or rejection of late breaking abstracts will be e-mailed in February 2015. The final selection of abstracts for presentation and placement of accepted abstracts in the program format will be made by the Program Committee.